TORONTO, Aug. 21,
2023 /PRNewswire/ - Dan Legault, Chief Executive
Officer and Director, Antibe Therapeutics Inc. (TSX: ATE) shares
his Company's story in an interview with TMX
Group.
The View From The C-Suite video interview series highlights the
unique perspectives of listed companies on Toronto Stock Exchange
and TSX Venture Exchange. Videos provide insight into how
company executives think in the current business
environment. To see the latest View From The C-Suite visit
https://www.tmxmoney.com/en/csuite.html.
About Antibe Therapeutics (TSX: ATE)
Antibe Therapeutics is a clinical-stage biotech company
developing next-generation, safer medicines for pain and
inflammation. The company's proprietary drug platform is designed
to overcome the gastrointestinal ulcers and bleeding associated
with NSAIDs, a class of drugs used by most North Americans and by
billions of people globally. https://antibethera.com/
CNW sponsored announcement. To learn more visit
www.newswire.ca.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/toronto-stock-exchange-antibe-therapeutics--inc-view-from-the-c-suite-301905939.html
SOURCE Toronto Stock Exchange